István Tóth

Q: What Schools Are Affiliated With István Tóth

István Tóth is affiliated with the following schools: University of Queensland, Griffith University, University of Melbourne, University of Manitoba, Budapest University of Technology and Economics

István Tóth 's AcademicInfluence.com Rankings

István Tóth

Chemistry

#3085

World Rank

#4073

Historical Rank

Chemical Engineering

#332

World Rank

#346

Historical Rank

chemistry Degrees

Download Badge

Chemistry

István Tóth 's Degrees

Bachelors Chemical Engineering University of Melbourne

Why Is István Tóth Influential?

(Suggest an Edit or Addition)

According to Wikipedia, István Tóth is an Australian scientist and chemical engineer. He is the Chair of Biological Chemistry and Professor of Pharmacy at the University of Queensland. Education Has a Master's in Chemical Engineering and a Ph.D. from the Technical University Budapest and is a member of the Hungarian Academy of Sciences. Toth is also a fellow of the Queensland Academy of Art and Sciences and Royal Australian Chemical Institute, and Affiliated Professorial Research Fellow and Group Leader at Institute of Molecular Biosciences, UQ.

(See a Problem?)

István Tóth 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. (2011) (754)
Peptide-based synthetic vaccines (2015) (371)
Modern Subunit Vaccines: Development, Components, and Research Opportunities (2013) (301)
Recent advances in self‐assembled peptides: Implications for targeted drug delivery and vaccine engineering (2017) (224)
Recent progress in adjuvant discovery for peptide-based subunit vaccines (2014) (177)
Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. (2012) (168)
Cellular uptake of densely packed polymer coatings on gold nanoparticles. (2010) (167)
Recent advances in peptide-based subunit nanovaccines. (2014) (154)
Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity (2005) (151)
Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system. (2010) (149)
Chemical Methods for Peptide and Protein Production (2013) (148)
DNA transfection and transfected cell viability using amphipathic asymmetric dendrimers. (2000) (139)
Improved resistance to serum oxidation in Gilbert's syndrome: a mechanism for cardiovascular protection. (2008) (129)
Self-adjuvanting lipopeptide vaccines. (2008) (129)
Peptides as therapeutics with enhanced bioactivity. (2012) (129)
Lipidic peptides, I. Synthesis, resolution and structural elucidation of lipidic amino acids and their homo- and hetero-oligomers (1990) (126)
Glycosylation, an effective synthetic strategy to improve the bioavailability of therapeutic peptides (2016) (125)
Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses (2012) (124)
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. (2003) (122)
A novel chemical approach to drug delivery: lipidic amino acid conjugates. (1994) (118)
A new principle for tight junction modulation based on occludin peptides. (2003) (116)
A Global Review on Short Peptides: Frontiers and Perspectives † (2021) (113)
Nanovaccines and their mode of action. (2013) (112)
Peptide-based subunit nanovaccines. (2011) (111)
Self-adjuvanting polymer-peptide conjugates as therapeutic vaccine candidates against cervical cancer. (2013) (103)
Oral delivery of nanoparticle-based vaccines (2014) (102)
Oral uptake and translocation of a polylysine dendrimer with a lipid surface. (2000) (100)
Strategies for intranasal delivery of vaccines (2012) (98)
Inhibition of in vitro VEGF expression and choroidal neovascularization by synthetic dendrimer peptide mediated delivery of a sense oligonucleotide. (2004) (91)
Liposome-based delivery system for vaccine candidates: constructing an effective formulation. (2012) (90)
Lipid, sugar and liposaccharide based delivery systems 2. (2004) (85)
Micro- and nanotechnology in vaccine development (2016) (79)
Immunogenicity evaluation of a lipidic amino acid-based synthetic peptide vaccine for Chlamydia trachomatis. (1993) (78)
Cellular uptake of self-assembled cationic peptide-DNA complexes: multifunctional role of the enhancer chloroquine. (2009) (78)
Peptide Conjugation via CuAAC ‘Click’ Chemistry (2013) (74)
Liposomes as nanovaccine delivery systems. (2014) (73)
Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine. (2011) (72)
A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilising lipidic amino acids (1993) (69)
Immunostimulation by Synthetic Lipopeptide-Based Vaccine Candidates: Structure-Activity Relationships (2013) (68)
Synthesis and biological evaluation of an orally active glycosylated endomorphin-1. (2012) (67)
Mucosal immunisation: adjuvants and delivery systems. (2004) (64)
Potential of Lipid Core Peptide Technology as a Novel Self-Adjuvanting Vaccine Delivery System for Multiple Different Synthetic Peptide Immunogens (2003) (64)
Particulate systems as adjuvants and carriers for peptide and protein antigens. (2006) (62)
Synthesis, structure elucidation, in vitro biological activity, toxicity, and Caco-2 cell permeability of lipophilic analogues of alpha-conotoxin MII. (2003) (59)
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines (2020) (59)
A Lipid Core Peptide Construct Containing a Conserved Region Determinant of the Group A Streptococcal M Protein Elicits Heterologous Opsonic Antibodies (2002) (58)
Structure-activity relationship of a series of synthetic lipopeptide self-adjuvanting group a streptococcal vaccine candidates. (2008) (58)
Cell-Penetrating Peptides: Efficient Vectors for Vaccine Delivery (2019) (57)
Toll-like receptor agonists: a patent review (2011 – 2013) (2014) (57)
Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus. (2018) (57)
Advances in peptide-based human papillomavirus therapeutic vaccines. (2012) (56)
Synthesis of C-terminal glycopeptides from resin-bound glycosyl azides via a modified Staudinger reaction. (2000) (56)
Versatile peptide dendrimers for nucleic acid delivery. (2005) (56)
Polymers for subunit vaccine delivery (2019) (55)
Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus. (2016) (54)
Interaction of densely polymer-coated gold nanoparticles with epithelial Caco-2 monolayers. (2011) (54)
Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus. (2016) (53)
Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase. (2007) (53)
Encapsulation of lipopeptides within liposomes: effect of number of lipid chains, chain length and method of liposome preparation. (2005) (51)
Syntheses of polycationic dendrimers on lipophilic peptide core for complexation and transport of oligonucleotides. (2002) (50)
Synthesis and in vitro evaluation of a library of modified endomorphin 1 peptides. (2008) (49)
Lipidic conjugates of luteinizing hormone releasing hormone (LHRH)+ and thyrotropin releasing hormone (TRH)+ that release and protect the native hormones in homogenates of human intestinal epithelial (Caco-2) cells (1994) (49)
Intranasal delivery of nanoparticle-based vaccines. (2017) (49)
Synthesis and Physicochemical Properties of Lipophilic Polyamide Dendrimers (1998) (48)
Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery. (2011) (47)
Cellular transport pathways of polymer coated gold nanoparticles. (2012) (47)
Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship (2012) (46)
Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery (2009) (46)
Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine. (2015) (46)
Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation. (2007) (46)
Site-specific incorporation of three toll-like receptor 2 targeting adjuvants into semisynthetic, molecularly defined nanoparticles: application to group a streptococcal vaccines. (2014) (45)
Polyelectrolyte-Based Platforms for the Delivery of Peptides and Proteins. (2019) (45)
The application of self-assembled nanostructures in peptide-based subunit vaccine development (2017) (45)
Recent Advances in the Development of Peptide Vaccines and Their Delivery Systems against Group A Streptococcus (2019) (44)
Technological advances in antigen delivery and synthetic peptide vaccine developmental strategies. (2001) (44)
Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery. (2016) (44)
Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. (2006) (43)
Toward the development of prophylactic and therapeutic human papillomavirus type-16 lipopeptide vaccines. (2007) (42)
Lipophilic methotrexate conjugates with antitumor activity. (2000) (42)
Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models (2016) (42)
Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2. (2010) (42)
Modern lipid‐, carbohydrate‐, and peptide‐based delivery systems for peptide, vaccine, and gene products (2011) (41)
Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid‐core peptide technology (2002) (41)
Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: correlation with hemolytic potency and implications for drug delivery. (2004) (41)
Specific Modulation of Airway Epithelial Tight Junctions by Apical Application of an Occludin Peptide (2006) (41)
Oral vaccine delivery--new strategies and technologies. (2009) (40)
Polymer-peptide hybrids as a highly immunogenic single-dose nanovaccine. (2014) (40)
An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model (2019) (40)
Self-adjuvanting vaccine against group A streptococcus: application of fibrillized peptide and immunostimulatory lipid as adjuvant. (2014) (39)
Synthesis and in vitro evaluation of lipoamino acid and carbohydrate-modified enkephalins as potential antinociceptive agents (1998) (39)
Gastrointestinal absorption of heparin by lipidization or coadministration with penetration enhancers. (2005) (39)
An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity. (2017) (39)
Endosome Escape Strategies for Improving the Efficacy of Oligonucleotide Delivery Systems. (2015) (38)
Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function. (2006) (38)
Structure-activity relationship for the development of a self-adjuvanting mucosally active lipopeptide vaccine against Streptococcus pyogenes. (2012) (38)
Liposomes as a Vaccine Delivery System (2017) (38)
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity. (2014) (38)
Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. (2006) (37)
Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus. (2016) (37)
Neighboring group participation Part 15. Stereoselective synthesis of some steroidal tetrahydrooxazin-2-ones, as novel presumed inhibitors of human 5α-reductase (2004) (37)
Novel lipoamino acid- and liposaccharide-based system for peptide delivery: application for oral administration of tumor-selective somatostatin analogues. (1999) (37)
Peptide-Based Subunit Vaccine against Hookworm Infection (2012) (36)
Polycationic lipophilic-core dendrons as penetration enhancers for the oral administration of low molecular weight heparin. (2006) (35)
Lipid- and sugar-modified endomorphins: novel targets for the treatment of neuropathic pain (2013) (35)
Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. (2005) (34)
Development of a liposaccharide-based delivery system and its application to the design of group A streptococcal vaccines. (2008) (34)
Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation. (2006) (34)
Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand. (2012) (33)
Synthesis of a library of polycationic lipid core dendrimers and their evaluation in the delivery of an oligonucleotide with hVEGF inhibition. (2006) (33)
Berbanes: a new class of selective alpha 2-adrenoceptor antagonists. (1987) (33)
Novel cationic lipidic peptide dendrimer vectors in vitro gene delivery (1999) (32)
Distribution of a lipidic 2.5 nm diameter dendrimer carrier after oral administration. (1999) (32)
Non-invasive mucosal vaccine delivery: advantages, challenges and the future (2020) (32)
Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components. (2010) (32)
A novel synthetic adjuvant enhances dendritic cell function (2009) (32)
Lipid Peptide Core Nanoparticles as Multivalent Vaccine Candidates against Streptococcus pyogenes (2012) (31)
Levofloxacin and indolicidin for combination antimicrobial therapy. (2015) (31)
The contribution of non-human primate models to the development of human vaccines. (2014) (31)
Immunogenicity of Liposomes Containing Lipid Core Peptides and the Adjuvant Quil A (2006) (31)
An efficient, chemically-defined semisynthetic lipid-adjuvanted nanoparticulate vaccine development system. (2013) (31)
Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells. (2017) (31)
Lipo-Endomorphin-1 Derivatives with Systemic Activity against Neuropathic Pain without Producing Constipation (2012) (31)
Lipopeptide-based oral vaccine against hookworm infection. (2020) (30)
Multiantigenic peptide-polymer conjugates as therapeutic vaccines against cervical cancer. (2016) (30)
Stereoselective synthesis of some 17β-dihydrooxazinyl steroids, as novel presumed inhibitors of 17α-hydroxylase-C17,20-lyase (2006) (29)
A mass spectrometric line for tritium analysis of water and noble gas measurements from different water amounts in the range of microlitres and millilitres (2012) (29)
Molecular Pathomechanisms and New Trends in Drug Research (2007) (29)
Schistosome Vaccine Adjuvants in Preclinical and Clinical Research (2014) (29)
Protein transduction by lipidic peptide dendrimers. (2006) (28)
Carbohydrate-based templates for synthetic vaccines and drug delivery (2001) (28)
Intravitreal injection of lipoamino acid-modified connexin43 mimetic peptide enhances neuroprotection after retinal ischemia (2015) (28)
Design, synthesis, and evaluation of a liposaccharide drug delivery agent: application to the gastrointestinal absorption of gentamicin. (2004) (28)
Lipid, sugar and liposaccharide based delivery systems. (2001) (27)
Recent advances in the development of subunit-based RSV vaccines (2016) (27)
Novel liposaccharide conjugates for drug and peptide delivery. (1998) (27)
Method for the synthesis of highly pure vaccines using the lipid core peptide system (2006) (27)
Co-polymerised peptide particles (CPP) I: synthesis, characterisation and in vitro studies on a novel oral nanoparticulate delivery system (1996) (26)
Enhancement of drug affinity for cell membranes by conjugation with lipoamino acids II. Experimental and computational evidence using biomembrane models. (2006) (26)
Role of Tachykinin 1 and 4 Gene-Derived Neuropeptides and the Neurokinin 1 Receptor in Adjuvant-Induced Chronic Arthritis of the Mouse (2013) (26)
solid phase synthesis of C-terminal carbohydrate modified enkephalins (1997) (26)
Short cationic lipopeptides as effective antibacterial agents: Design, physicochemical properties and biological evaluation. (2016) (26)
Self-assembly of trimethyl chitosan and poly(anionic amino acid)-peptide antigen conjugate to produce a potent self-adjuvanting nanovaccine delivery system. (2019) (25)
Lipo-Peptides/Saccharides for Peptide Vaccine Delivery (2013) (25)
Co-polymerised peptide particles II: Oral uptake of a novel co-polymeric nanoparticulate delivery system for peptides (1996) (25)
The use of a conformational cathepsin D-derived epitope for vaccine development against Schistosoma mansoni. (2015) (25)
Chemical Conjugation Strategies for the Development of Protein-Based Subunit Nanovaccines (2021) (25)
Increasing entrapment of peptides within poly(alkyl cyanoacrylate) nanoparticles prepared from water-in-oil microemulsions by copolymerization. (2008) (25)
Design, synthesis and biological evaluation of novel lipoamino acid-based glycolipids for oral drug delivery. (2007) (24)
Novel platform technology for modular mucosal vaccine that protects against streptococcus (2016) (24)
Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus. (2017) (24)
Biological properties and therapeutic potential of bilirubin. (2003) (24)
Lipids as activators of innate immunity in peptide vaccine delivery. (2018) (24)
Urotensin-II-Converting Enzyme Activity of Furin and Trypsin in Human Cells in Vitro (2004) (24)
Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite (2015) (24)
Hydride abstraction in fast atom bombardment (1988) (24)
A semi-synthetic whole parasite vaccine designed to protect against blood stage malaria. (2016) (24)
Simple synthetic toll-like receptor 2 ligands. (2011) (23)
The synthesis and characterisation of a novel dendritic system for gene delivery (2007) (23)
Investigation of bombesin peptide as a targeting ligand for the gastrin releasing peptide (GRP) receptor. (2016) (23)
Structure-activity relationship of lipid core peptide-based Group A Streptococcus vaccine candidates. (2016) (23)
Lipoamino acid-based adjuvant carrier system: enhanced immunogenicity of group a streptococcal peptide epitopes. (2002) (23)
In vitro stability and permeability studies of liposomal delivery systems for a novel lipophilic endomorphin 1 analogue. (2008) (22)
In vitro permeability and metabolic stability of bile pigments and the effects of hydrophilic and lipophilic modification of biliverdin. (2008) (22)
Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A Streptococcus (2020) (22)
Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathy. (2013) (22)
Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system. (2019) (22)
Recent advances in oral delivery of peptide hormones (2016) (22)
Self-adjuvanting therapeutic peptide-based vaccine induce CD8+ cytotoxic T lymphocyte responses in a murine human papillomavirus tumor model. (2015) (22)
Efficient synthesis of thioglycosides via a Mitsunobu condensation. (1999) (22)
Oral absorption studies of lipid-polylysine conjugates of thyrotropin releasing hormone (TRH1) and luteinizing hormone releasing hormone (LHRH1) (1996) (21)
Synthetic polyacrylate polymers as particulate intranasal vaccine delivery systems for the induction of mucosal immune response. (2010) (21)
Lipoamino acid conjugates of methotrexate with antitumor activity. (1998) (21)
Carbohydrate Immune Adjuvants in Subunit Vaccines (2020) (21)
Cyclic Dipeptides: The Biological and Structural Landscape with Special Focus on the Anti-Cancer Proline-Based Scaffold (2021) (21)
Recent Advances in Design and Synthesis of Self-Adjuvanting Lipopeptide Vaccines (2008) (21)
Synthesis and immunological evaluation of self-adjuvanting glycolipopeptide vaccine candidates. (2008) (21)
Oral absorption and in vivo biodistribution of α-conotoxin MII and a lipidic analogue (2007) (21)
Conversion of glucosamine to galactosamine and allosamine derivatives: control of inversions of stereochemistry at C-3 and C-4. (2001) (21)
The Role of Size in Development of Mucosal Liposome-Lipopeptide Vaccine Candidates Against Group A Streptococcus. (2016) (21)
Development of highly pure α-helical lipoglycopeptides as self-adjuvanting vaccines (2009) (21)
Lipid core peptide technology and group A streptococcal vaccine delivery (2004) (21)
Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein (2017) (21)
Method for the synthesis of multi-epitopic Streptococcus pyogenes lipopeptide vaccines using native chemical ligation. (2006) (21)
Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage. (2004) (21)
Polyacrylate–Peptide Antigen Conjugate as a Single-Dose Oral Vaccine against Group A Streptococcus (2020) (21)
Synthesis and in vivo studies of carbohydrate-based vaccines against group A streptococcus. (2008) (20)
Vaccination with Lipid Core Peptides Fails to Induce Epitope-Specific T Cell Responses but Confers Non-Specific Protective Immunity in a Malaria Model (2012) (20)
M-protein-derived conformational peptide epitope vaccine candidate against Group A Streptococcus. (2013) (20)
Neighboring group participation Part 17 Stereoselective synthesis of some steroidal 2-oxazolidones, as novel potential inhibitors of 17α-hydroxylase-C17,20-lyase (2008) (20)
Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. (2011) (19)
Design and Synthesis of Lipopeptide–Carbohydrate Assembled Multivalent Vaccine Candidates Using Native Chemical Ligation (2009) (19)
Synthesis and in vitro evaluation of glycosyl derivatives of luteinizing hormone-releasing hormone (LHRH). (2013) (19)
Effect of polymer grafting density on silica nanoparticle toxicity. (2012) (19)
Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis. (2010) (19)
Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. (2002) (18)
Cholic Acid-based Delivery System for Vaccine Candidates against Group A Streptococcus. (2019) (18)
Peptide-based targeted polymeric nanoparticles for siRNA delivery (2019) (18)
Bivalent mucosal peptide vaccines administered using the LCP carrier system stimulate protective immune responses against Streptococcus pyogenes infection. (2017) (18)
Targeting the mannose receptor with mannosylated subunit vaccines. (2014) (18)
Towards the Development of Synthetic Antibiotics: Designs Inspired by Natural Antimicrobial Peptides. (2016) (18)
Oral absorption of lipidic amino acid conjugates (1994) (17)
Epidermal Penetration of a Therapeutic Peptide by Lipid Conjugation; Stereo-Selective Peptide Availability of a Topical Diastereomeric Lipopeptide (2006) (17)
Nucleophilic substitution reactions of pyranose polytosylates. (2004) (17)
Poly(hydrophobic amino acid)-Based Self-Adjuvanting Nanoparticles for Group A Streptococcus Vaccine Delivery. (2021) (17)
Linear and branched polyacrylates as a delivery platform for peptide-based vaccines. (2016) (17)
Endomorphin derivatives with improved pharmacological properties. (2013) (17)
A Combined Adjuvant and Carrier System for Enhancing Synthetic Peptides Immunogenicity Utilizing Lipidic Amino Acids. (1993) (17)
Oral absorption enhancement of dipeptide L-Glu-L-Trp-OH by lipid and glycosyl conjugation. (2008) (17)
Lipid and carbohydrate based adjuvant/carriers in immunology (2003) (17)
Peripherally acting novel lipo-endomorphin-1 peptides in neuropathic pain without producing constipation. (2013) (16)
Double conjugation strategy to incorporate lipid adjuvants into multiantigenic vaccines (2016) (16)
Cell-penetrating peptides in vaccine delivery: facts, challenges and perspectives. (2019) (16)
A lipophilic adjuvant carrier system for antigenic peptides (2001) (16)
Microwave-assisted synthesis of difficult sequence-containing peptides using the isopeptide method. (2013) (16)
Circular dichroism, molecular modeling, and serology indicate that the structural basis of antigenic variation in foot-and-mouth disease virus is alpha-helix formation. (1994) (16)
The Use of Microwave-Assisted Solid-Phase Peptide Synthesis and Click Chemistry for the Synthesis of Vaccine Candidates Against Hookworm Infection. (2016) (16)
Induction of Plasmodium-Specific Immune Responses Using Liposome-Based Vaccines (2019) (16)
N-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl (N-Dde) Lipoamino Acids (2008) (16)
Lipidic Peptides, XIV. Conversion of Racemic Lipidic Amino Acids into Sphingosine and Ceramide Analogues and 1,2‐Diamines (1992) (15)
Ovalbumin lipid core peptide vaccines and their CD4(+) and CD8(+) T cell responses. (2014) (15)
Modification of peptides and other drugs using lipoamino acids and sugars. (2005) (15)
Lipoamino acids as major components of absorption promoters in drug delivery. (2012) (15)
Lipidic peptides. II. Synthesis, activity and transport of anti-inflammatory benzoquinolizine-lipidic peptide conjugates (1991) (15)
Structural effects of lipophilic methotrexate conjugates on model phospholipid biomembranes (2001) (15)
A technique for the synthesis of highly-pure, mono-epitopic, multi-valent lipid core peptide vaccines (2007) (15)
The stability of lipidic analogues of GnRH in plasma and kidney preparations: the stereoselective release of the parent peptide. (2005) (15)
The characterization of a novel dendritic system for gene delivery by isothermal titration calorimetry. (2008) (15)
Developments in Vaccine Adjuvants. (2021) (15)
Active immunisation of mice with GnRH lipopeptide vaccine candidates: Importance of T helper or multi-dimer GnRH epitope. (2014) (14)
Investigation of the route of absorption of lipid and sugar modified leu-enkephalin analogues and their enzymatic stability using the caco-2 cell monolayer system. (2006) (14)
Increased adjuvant activity of minimal CD8 T cell peptides incorporated into lipid‐core‐peptides (2004) (14)
Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct. (2004) (14)
Development of natural and unnatural amino acid delivery systems against hookworm infection (2020) (14)
Design of potent lipophilic-peptide inhibitors of human neutrophil elastase: In vitro and in vivo studies (1995) (14)
Immunology of carbohydrate-based vaccines. (2020) (14)
A Drug Delivery Strategy: Binding Enkephalin to Asialoglycoprotein Receptor by Enzymatic Galactosylation (2014) (13)
Modified influenza virosomes: recent advances and potential in gene delivery. (2007) (13)
Functional implications of modifying RyR‐activating peptides for membrane permeability (2005) (13)
Investigation toward multi-epitope vaccine candidates using native chemical ligation. (2008) (13)
Progress in the Development of Subunit Vaccines against Malaria (2020) (12)
Lipidic peptides. III: Lipidic amino acid and oligomer conjugates of morphine. (1991) (12)
Bombesin/oligoarginine fusion peptides for gastrin releasing peptide receptor (GRPR) targeted gene delivery. (2018) (12)
Polyethylenimine: An Intranasal Adjuvant for Liposomal Peptide-Based Subunit Vaccine against Group A Streptococcus. (2020) (12)
The synthesis and characterization of lipophilic peptide-based carriers for gene delivery (2010) (12)
Synthesis of Sialyl Lewis X Analogues (1996) (12)
Key Considerations for the Development of Safe and Effective SARS‐CoV‐2 Subunit Vaccine: A Peptide‐Based Vaccine Alternative (2021) (12)
A novel method for solid-phase synthesis of oligosaccharides using the N-1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl (Dde) linker (2001) (12)
Dendrimers in vaccine delivery: Recent progress and advances. (2021) (12)
An Economical Synthesis of Lewis X, Sialyl Lewis X and Their α-Galactosyl Analogues (1997) (12)
Design and evaluation of a stearylated multicomponent peptide-siRNA nanocomplex for efficient cellular siRNA delivery. (2017) (12)
Evaluation of cell tolerability of a series of lipoamino acids using biological membranes and a biomembrane model. (2007) (12)
Nanosized, peptide-based multicomponent DNA delivery systems: optimization of endosome escape activity. (2016) (12)
Advances in targeted gene delivery. (2019) (12)
Lipidic peptides. V: Penicillin and cephalosporin acid conjugates with increased lipophilic character. (1992) (12)
Peptide-Based Nanovaccines in the Treatment of Cervical Cancer: A Review of Recent Advances (2022) (11)
Pre-clinical evaluation of a whole-parasite vaccine to control human babesiosis. (2021) (11)
A novel method for preparing immune stimulating complexes (ISCOMs) by hydration of freeze-dried lipid matrix. (2007) (11)
Enhanced Transdermal Peptide Delivery and Stability by Lipid Conjugation: Epidermal Permeation, Stereoselectivity and Mechanistic Insights (2014) (11)
Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus (2021) (11)
Stability, Permeability and Growth-Inhibitory Properties of Gonadotropin-Releasing Hormone Liposaccharides (2015) (11)
Thymine, adenine and lipoamino acid based gene delivery systems. (2010) (11)
Towards the development of a broadly protective group a streptococcal vaccine based on the Lipid-Core Peptide system. (2007) (11)
Group A Streptococcal Vaccine Candidates based on the Conserved Conformational Epitope from M Protein (2011) (11)
Systematic evaluation of self-adjuvanting lipopeptide nano-vaccine platforms for the induction of potent CD8(+) T-cell responses. (2016) (11)
Convergent synthetic methodology for the construction of self-adjuvanting lipopeptide vaccines using a novel carbohydrate scaffold (2014) (10)
The synthesis and structure of an n-terminal dodecanoic acid conjugate of α-conotoxin MII (2001) (10)
The transport and efflux of glycosylated luteinising hormone-releasing hormone analogues in caco-2 cell model: contributions of glucose transporters and efflux systems. (2014) (10)
Lipophilic methotrexate conjugates with glucose‐lipoamino acid moieties: Synthesis and in vitro antitumor activity (2001) (10)
In vitro antimalarial and cytotoxic activities of semisynthetic derivatives of brusatol (1993) (10)
Antimicrobial Activity Enhancers: Towards Smart Delivery of Antimicrobial Agents (2022) (10)
Dde as a Protecting Group for Carbohydrate Synthesis (2006) (10)
pH-Triggered peptide self-assembly into fibrils: a potential peptide-based subunit vaccine delivery platform (2013) (10)
Synthesis of a Streptococcus pyogenes vaccine candidate based on the M protein PL1 epitope. (2009) (10)
Synthesis, biological activity and structure-activity relationship of endomorphin-1/substance P derivatives. (2012) (10)
Peptide-based vaccines (2018) (10)
Design and synthesis of a series of novel, cationic liposaccharide derivatives as potential penetration enhancers for oral drug delivery (2009) (10)
Synthesis and characterisation of self-assembled and self-adjuvanting asymmetric multi-epitope lipopeptides of ovalbumin. (2015) (10)
Liposomal formulation of polyacrylate-peptide conjugate as a new vaccine candidate against cervical cancer (2018) (10)
Advances in Infectious Disease Vaccine Adjuvants (2022) (10)
Biophysical characterization of lectin-glycan interactions for therapeutics, vaccines and targeted drug-delivery. (2014) (10)
Novel cationic lipophilic peptides for oligodeoxynucleotide delivery. (2007) (9)
Comparison of the in vitro apparent permeability and stability of opioid mimetic compounds with that of the native peptide. (2007) (9)
Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains. (2015) (9)
Caco-2 cell permeability and stability of two d-glucopyranuronamide conjugates of thyrotropin-releasing hormone. (2007) (9)
Peptide Conjugation via CuAAC ′Click′ Chemistry (2014) (9)
The immune system likes nanotechnology. (2014) (9)
Lipidic peptides. VIII. Cellular uptake studies of lipidic amino acid, its oligomers and highly lipophilic drug conjugates (1992) (9)
Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines. (2009) (9)
Synthesis of Mannosylated Lipopeptides with Receptor Targeting Properties. (2016) (9)
Chemo-enzymatic synthesis of a trisaccharide-linked peptide aimed at improved drug-delivery. (2005) (9)
Enhancement of oral drug absorption-effect of lipid conjugation on the enzymatic stability and intestinal permeability of l-Glu-l-Trp-NH(2). (2007) (9)
Dendritic peptide-based carriers for gene delivery. (2009) (9)
Synthesis, Characterization and Immunological Evaluation of Self‐Adjuvanting Group A Streptococcal Vaccine Candidates Bearing Various Lipidic Adjuvanting Moieties (2017) (9)
Failure to demonstrate intestinal absorption of RNA in the newborn pig. Preliminary communication. (1986) (9)
Transdermal delivery of a tetrapeptide: Evaluation of passive diffusion (2003) (9)
Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs (2015) (9)
Synthesis and spectroscopy of membrane receptor proteins. The gamma subunit of the IgE receptor. (1992) (8)
Anti-proliferative effects of novel glyco-lipid-arsenicals (III) on MCF-7 human breast cancer cells. (2006) (8)
Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection (2003) (8)
Optimized LC-MS/MS quantification method for the detection of piperacillin and application to the development of charged liposaccharides as oral penetration enhancers. (2008) (8)
In vitro and in vivo evaluation of positively charged liposaccharide derivatives as oral absorption enhancers for the delivery of anionic drugs. (2010) (8)
Effect of lipidated gonadotropin-releasing hormone peptides on receptor mediated binding and uptake into prostate cancer cells in vitro. (2014) (8)
Lipidic peptides. IV. Penicillin and cephalosporin amide conjugates with lipidic amino acids and their oligomers (1991) (8)
Comparison of Fluorinated and Nonfluorinated Lipids in Self-Adjuvanting Delivery Systems for Peptide-Based Vaccines. (2017) (8)
Oral absorption and in vivo biodistribution of alpha-conotoxin MII and a lipidic analogue. (2007) (8)
Peptide based DNA nanocarriers incorporating a cell-penetrating peptide derived from neurturin protein and poly-L-lysine dendrons. (2015) (8)
A study on liposomal encapsulation of a lipophilic prodrug of LHRH (2015) (8)
Poly-L-lysine-coated nanoparticles are ineffective in inducing mucosal immunity against group a streptococcus (2017) (8)
Oral Peptide Vaccine against Hookworm Infection: Correlation of Antibody Titers with Protective Efficacy (2021) (8)
Lipidic peptides X. Synthesis, structural and physico-chemical elucidation of lipidic amino acid conjugates with hydrophilic compounds☆ (1992) (8)
A study on the encapsulation of an occludin lipophilic derivative in liposomal carriers (2015) (8)
Influence of Physicochemical Properties of Lipopeptide Adjuvants on the Immune Response: A Rationale for Engineering a Potent Vaccine. (2018) (8)
Synthesis and Immunological Evaluation of M Protein Targeted Tetra-Valent and Tri-Valent Group A Streptococcal Vaccine Candidates Based on the Lipid-Core Peptide System (2006) (7)
Lipidated analogues of luteinizing hormone-releasing hormone (LHRH) reduce serum levels of follicle-stimulating hormone (FSH) after oral administration. (2012) (7)
Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2 (2021) (7)
Investigations on the chemistry of berbanes. 10. Synthesis of raunescinone analogues with hypotensive and antihypertensive activity. (1984) (7)
Synthesis and oral uptake studies of lipidic and glyco-lipidic conjugates of β-lactam antibiotics (1994) (7)
Mannosylated liposomes formulated with whole parasite P. falciparum blood-stage antigens are highly immunogenic in mice. (2019) (7)
Development of New Gonadotropin-Releasing Hormone-Modified Dendrimer Platforms with Direct Antiproliferative and Gonadotropin Releasing Activity. (2017) (7)
Formulation, characterization and permeability study of nano particles of lipo-endomorphin-1 for oral delivery (2013) (7)
Calorimetry and Langmuir-Blodgett studies on the interaction of a lipophilic prodrug of LHRH with biomembrane models. (2014) (7)
Identification of Host Insulin Binding Sites on Schistosoma japonicum Insulin Receptors (2016) (7)
Polyethylenimine quantity and molecular weight influence its adjuvanting properties in liposomal peptide vaccines. (2021) (7)
Synthesis of glycolipopeptidic building blocks for carbohydrate receptor discovery. (2011) (7)
Gastrin-releasing peptide receptor-targeted hybrid peptide/phospholipid pDNA/siRNA delivery systems. (2019) (7)
Development of conformational mimetics of conserved Streptococcus pyogenes minimal epitope as vaccine candidates. (2009) (7)
Modern Lipid-, Carbohydrate-, and Peptide-Based Delivery Systems for Peptide, Vaccine, and Gene Products (2011) (7)
Peptide Synthesis: Methods and Protocols (2020) (7)
Synthesis and Plasma Stability of Disulfide-Bridged Cyclic Endomorphin-1 Derivatives (2012) (6)
Immunogenicity Assessment of Cell Wall Carbohydrates of Group A Streptococcus via Self-Adjuvanted Glyco-lipopeptides. (2021) (6)
α-1,4-Galactosyltransferase-catalyzed glycosylation of sugar and lipid modified Leu-enkephalins (2013) (6)
Self-assembled peptide-polymer conjugates as vaccines (2014) (6)
Use of Mixed Micelles for Presentation of Building Blocks in a New Combinatorial Discovery Methodology: Proof-of-Concept Studies (2013) (6)
The influence of incorporating lipids or liposaccharides on the particle size of peptide therapeutics (2011) (6)
Design, synthesis and evaluation of a gonadotropin releasing hormone-based subunit vaccine in rams (Ovis aries). (2015) (6)
Toll-like receptor 2 mediated dendritic cell activation: Key target for lipopeptide vaccines design (2010) (6)
Combined synthetic and recombinant techniques for the development of lipoprotein-based, self-adjuvanting vaccines targeting human papillomavirus type-16 associated tumors. (2015) (6)
Peptide-Based Multicomponent Oligonucleotide Delivery Systems: Optimisation of Poly-l-lysine Dendrons for Plasmid DNA Delivery (2017) (6)
Evaluation of Lipopeptides as Toll-like Receptor 2 Ligands. (2017) (6)
Lipidic peptides. XIII: Synthesis, structure elucidation and in vitro toxicity assessment of chlorambucil conjugates with lipidic acids, lipidic amino acids and their oligomers (1992) (6)
Lipidic Peptides. Part 1. Synthesis, Resolution and Structural Elucidation of Lipidic Amino Acids and Their Homo- and Hetero- Oligomers. (1991) (6)
Liposomes for Improved Enzymatic Glycosylation of Lipid-Modified Lactose Enkephalin. (2013) (5)
Development of lipid-core-peptide (LCP) based vaccines for the prevention of group A streptococcal (GAS) infection (2003) (5)
Liposomes for the Delivery of Lipopeptide Vaccines. (2021) (5)
Lipidic peptides, VII. Synthesis and structure elucidation of γ‐aminobutyric acid conjugates with lipidic acids, lipidic amino acids and lipidic peptides (1991) (5)
Lipidic Peptides, IX. Synthesis and Structural Elucidation of Lipophilic Azidothymidine Conjugates (1992) (5)
A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus: Lipidation and polyelectrolyte complexes. (2020) (5)
In vivo pharmacological evaluation of a lactose-conjugated luteinizing hormone releasing hormone analogue. (2015) (5)
Design, synthesis and characterisation of mannosylated ovalbumin lipid core peptide self-adjuvanting vaccine delivery system (2014) (5)
Polyacrylate-GnRH Peptide Conjugate as an Oral Contraceptive Vaccine Candidate (2021) (5)
Detection and Quantification of SARS-CoV-2 Receptor Binding Domain Neutralization by a Sensitive Competitive ELISA Assay (2021) (5)
Investigation of Structure–Activity Relationships of Synthetic Anti‐Gonadotropin Releasing Hormone Vaccine Candidates (2015) (5)
Brain Delivery of Thyrotropin-Releasing Hormone via a Novel Prodrug Approach (2019) (5)
Poly(hydrophobic amino acid) Conjugates for the Delivery of Multiepitope Vaccine against Group A Streptococcus. (2021) (5)
Structure-Activity Analysis of Cyclic Multicomponent Lipopeptide Self-Adjuvanting Vaccine Candidates Presenting Group A Streptococcus Antigens. (2020) (5)
Spectroscopic and conformational studies of the C-terminal cytoplasmic beta subunit 46-peptide of the high affinity IgE receptor. (1994) (4)
Lipidic peptides. XI. Quantitative structure-activity relationships of a series of lipidic amino acid conjugates of β-lactam antibiotics (1992) (4)
Internalisation of the mu-opioid receptor by endomorphin-1 and leu-enkephalin is dependant on aromatic amino acid residues. (2008) (4)
Development and characterization of anionic liposaccharides for enhanced oral drug delivery. (2012) (4)
Synthesis and immunological evaluation of peptide-based vaccine candidates against malaria (2016) (4)
Lipopeptides for the Fragment-Based Pharmaceutics Design (2012) (4)
Application of Fmoc-SPPS, Thiol-Maleimide Conjugation, and Copper(I)-Catalyzed Alkyne-Azide Cycloaddition "Click" Reaction in the Synthesis of a Complex Peptide-Based Vaccine Candidate Against Group A Streptococcus. (2020) (4)
Synthesis and Characterization of Luteinizing Hormone-Releasing Hormone (LHRH)-Functionalized Mini-Dendrimers (2013) (4)
Investigations on the Chemistry of Berbanes, XII. Synthesis of Pseudo-Depyrroloyohimbine Analogues (1987) (4)
Effect of variation in the chain length and number in modulating the interaction of an immunogenic lipopeptide with biomembrane models (2008) (4)
The influence of component structural arrangement on peptide vaccine immunogenicity. (2022) (4)
Opsonic Activity of Conservative Versus Variable Regions of the Group A Streptococcus M Protein (2020) (4)
N.m.r. studies of the cytoplasmic C-terminal beta-subunit domain of the high-affinity IgE receptor. (1994) (4)
Carbohydrates in Vaccine Development. (2019) (3)
New gonadotropin-releasing hormone glycolipids with direct antiproliferative activity and gonadotropin-releasing potency. (2017) (3)
Development of a Peptide Vaccine against Hookworm Infection: Immunogenicity, Efficacy, and Immune Correlates of Protection. (2022) (3)
Development of a hyperbranched polymer-based methotrexate nanomedicine for rheumatoid arthritis. (2022) (3)
Lipoamino Acids as Major Components of Absorption Promoters in Drug Delivery (2013) (3)
Towards synthetic vaccines built on carbohydrate cores (2001) (3)
Mannose in vaccine delivery. (2022) (3)
Synthesis, characterization and in vitro evaluation of amphiphilic ion pairs of erythromycin and kanamycin antibiotics with liposaccharides. (2016) (3)
Current Prospects in Peptide-Based Subunit Nanovaccines. (2021) (3)
Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems (2022) (3)
Development and Evaluation of a Cryopreserved Whole-Parasite Vaccine in a Rodent Model of Blood-Stage Malaria (2021) (3)
Investigation on the chemistry of berbans—VII: Synthesis of 10,11-dimethoxy(depyrrolo)raunescine stereoisomers (1978) (3)
A lipidic alpha-amino acid based synthetic adjuvant peptide complex for increasing immunogenicity of vaccines. (1994) (3)
Investigating the affinity of poly tert -butyl acrylate toward Toll-Like Receptor 2 (2018) (3)
Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus (2022) (3)
Synthesis of 14C‐labelled fluphenazine esters (1982) (3)
Synthetic lipopeptides formulated in liposomes: effect on their immune stimulatory capacity in vitro (2006) (2)
Corrigendum to “Pro-apoptotic activity of lipidic α-amino acids isolated from Protopalythoa variabilis” [Bioorg. Med. Chem. 18 (2010) 7997–8004] (2011) (2)
Semisynthetic Derivatives of Quassin (1998) (2)
Improved resistance to serum oxidation in Gilberts syndrome: a mechanism for cardiovascular protection (2008) (2)
Preparation of Trimethyl Chitosan-Based Polyelectrolyte Complexes for Peptide Subunit Vaccine Delivery. (2021) (2)
triggered peptide self-assembly into fibrils : a potential peptide-based subunit vaccine delivery platform Biochemical Compounds (2013) (2)
Current boundaries in the formulation of lipid based delivery systems (2016) (2)
Molecular Pathomechanisms and New Trends in Drug Design (2003) (2)
Development of Peptide Vaccines against HPV-16 Associated Cervical Cancer and Group A Streptococci (2006) (2)
Liposaccharide-based nanoparticulate drug delivery system (2012) (2)
Investigations on the Chemistry of Berbanes, XIII. Selective Reduction of Normal-, Allo-, Pseudo-, and Epiallo-Depyrrolo-Yohimbone Analogues (1987) (2)
Lipidic amino acid based synthetic peptide vaccine adjuvant (1993) (2)
Lipidic peptides. XII: Cellular uptake studies of a lipidic amino acid, its oligomers and highly lipophilic drug conjugates on Ehrlich ascites tumour cells (1992) (2)
Fluorinated Lipids Conjugated to Peptide Antigens do not Induce Immune Responses Against Cervical Cancer (2017) (2)
Investigation of urotensin-II converting enzyme activity in human cells and blood (2004) (2)
INVESTIGATIONS ON THE CHEMISTRY OF BERBANES. 10. SYNTHESIS OF RAUNESCINONE ANALOGS WITH HYPOTENSIVE AND ANTIHYPERTENSIVE ACTIVITY (1985) (1)
Peptide‐Based Synthetic Vaccines (2016) (1)
Liposomal Formulations of a Polyleucine–Antigen Conjugate as Therapeutic Vaccines against Cervical Cancer (2023) (1)
Synthesis of Fully and Partially Protected Alkyl 1-Thio-β-l-fucopyranosides (1995) (1)
Multi-layer engineered nanoliposomes as a novel tool for oral delivery of lipid core peptide-based vaccines against group A streptococcus ( GAS ) (2015) (1)
Conformational analysis of peptides from the high affinity receptor for IgE (1994) (1)
Sequence-specific anti-peptide antibodies that recognize different subunits of the high-affinity IgE receptor. (1993) (1)
Structure-activity relationship of lipid, cyclic peptide and antigen rearrangement of physically mixed vaccines. (2022) (1)
Model Liposomal Delivery System for Drugs and Vaccines (2020) (1)
Solid phase synthesis of C-terminal glycopeptides (2000) (1)
Microelements in cereals. (1990) (1)
Approaches to triterpene synthesis. Methyl group migration during catalytic hydrogenation of some precursors (1979) (1)
Lipophilic peptide inhibitors of ribonucleotide reductase enzyme of herpes simplex virus (1994) (1)
Polymeric Nanoparticles as a Self‐Adjuvanting Peptide Vaccine Delivery System: The Role of Shape (2023) (1)
Towards the development of subunit vaccines against tuberculosis: The key role of adjuvant. (2023) (1)
The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2 (2022) (1)
[Evaluation of serum alpha-1-fetoprotein studies in patients with testicular tumors receiving adjuvant and curative chemotherapy]. (1983) (1)
Nanocarrier-based vaccine delivery systems for synthetic peptide vaccines (2021) (1)
Spectroscopy and modelling of the cytoplasmic domain of the gamma-subunit of the high affinity immunoglobulin E receptor. (1994) (1)
Use of Synthetic Dendrimer Peptide’s to Mediate the Delivery of a Sense Oligonucleotide (2003) (1)
The Chemo-enzymatic Synthesis of Oligosaccharide-linked Peptides Aimed at Improved Drug Delivery (2006) (1)
Synthetic bicyclic analogues of quassinoids (1998) (1)
Novel lipoamino acid and liposaccharide based peptide delivery system for tumor selective somatostatin analogs (2000) (1)
The structures of 5-methyl-1,3-thiazolidin-2-one (2,6-dichlorophenyl)hydrazone and 1,3-thiazolidin-2-one (2,6-dimethylphenyl)hydrazone (1980) (1)
Physical Mixture of a Cyclic Lipopeptide Vaccine Induced High Titres of Opsonic IgG Antibodies against Group A Streptococcus (2021) (1)
Investigations on the Chemistry of Berbanes. Part 12. Synthesis of Pseudo-Depyrrolohimbine Analogues. (1987) (1)
Novel Glyco-lipid-arsenicals (III) with Anti-proliferative Effects on MCF-7 Human Breast Cancer Cells (2006) (1)
Developing an Effective Glycan‐based Vaccine for Streptococcus Pyogenes (2021) (1)
Biological Activity of Luteinizing Hormone Releasing Hormone after Oral Dosing with a Novel Nanoparticulate Delivery System: Co‐polymerized Peptide Particles (1996) (1)
Peptide-Polymer Conjugation Via Copper-Catalyzed Alkyne-Azide 1,3-Dipolar Cycloaddition. (2021) (1)
Design and synthesis of lipopeptides and lipopeptidomimetics as novel potential drugs (2011) (1)
Hookworm infection: Toward development of safe and effective peptide vaccines. (2021) (1)
Clinical trials with MTDQ /6,6'-methylene-bis (2,2,4-trimethyl-1,2-dihydroquinoline)/ an antioxidant with radiation sensitizing effect. (1980) (1)
Liposaccharides for improved oral delivery of tobramycin (2012) (1)
Enhancing peptide delivery using lipoamino acids and liposaccharides. (2001) (1)
Delivery of a lactose derivative of endomorphin 1 to the brain via the olfactory epithelial pathway. (2014) (1)
An Isodipeptide Building Block for Microwave-Assisted Solid-Phase Synthesis of Difficult Sequence-Containing Peptides. (2020) (1)
A Potent Vaccine Delivery System. (2021) (1)
Towards the synthesis of a highly pure, multiepitopic, mucosal group A streptococcal lipopeptide vaccine (2006) (1)
Synthesis of Sialyl Lewis X Analogues 2. (1997) (1)
Current Drug Delivery. Preface. (2014) (1)
Editorial: Thematic issue: nanotechnology for drug delivery applications. (2014) (1)
The synthesis and structure of an n-terminal dodecanoic acid conjugate of α-conotoxin MII (2006) (1)
A lipophilic adjuvant carrier system for antigenic peptides (2004) (1)
Lipoamino acid-modified GnRH analogs with receptor-mediated antiproliferative activity in prostate and ovarian cancer cells (2021) (1)
Towards synthetic vaccines built on carbohydrate cores (2006) (1)
Peptide-lipid-carbohydrate based vaccine against group A Streptococcal infection. (2007) (0)
Structure-activity relationships of potential self-adjuvanting vaccines against Group A streptococcus based on the carboxyl group of its M-protein (2006) (0)
Novel vaccine delivery systems (2004) (0)
Subunit Vaccine Design of the Schistosomiasis Japonica Insulin Receptor (2014) (0)
Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs (2015) (0)
Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing (2023) (0)
Epitopes formed by non-covalently associated conjugates (2000) (0)
Liposaccharides: Applications for oral peptide delivery (2000) (0)
Liposome-based delivery system for vaccine candidates: constructing an effective formulation (vol 7, pg 1877, 2012) (2013) (0)
Liposaccharides: Utilisation for Peptide Delivery and for Enhancing Synthetic Peptide Immunogenicity (2001) (0)
Lipopeptide-Based Vaccines (2010) (0)
Glycosylation of luteninzing hormone releasing hormoe: towards the development of orally active peptide (2014) (0)
Stability, Permeability and Growth-Inhibitory Properties of Gonadotropin-Releasing Hormone Liposaccharides (2014) (0)
Allosamines and galactosamines from glucosamine: Control of stereochemical inversions at C-3 and C-4 (2001) (0)
Carbohydrate-based carrier adjuvants in vaccine technology (2001) (0)
Preface [Hot topic: Carbohydrates (Executive Editor: Istvan Toth)] (2003) (0)
Inclusion complex of a phosphorus-containing organic calcium compound and of cyclodextrin, process for its preparation and its use for protecting plants (1986) (0)
Intranasal Delivery of Liposomes-Based Lipopeptide Hookworm Vaccine Diminished its Ability to Protect Mice Against Hookworm Challenge (2022) (0)
Modified connexin43 mimetic peptide shows higher efficacy in reducing retinal ganglion cell loss and vessel leak after retinal ischemia (2013) (0)
A synthetic group A streptococcal vaccine of high purity and broad protective range (2005) (0)
A novel liposaccharide system for the delivery of Endormorphin 1 (2004) (0)
Towards the development of self-adjuvanting vaccine against group A streptococcus (2015) (0)
Synthesis of Lipid LHRH Peptides for Targeted Drug Delivery (2013) (0)
By non-covalently associated conjugate formed epitope (2000) (0)
Lipoamino acid and liposaccharide based peptide delivery system (2000) (0)
Absorption and pharmacokinetics of bilirubin and biliverdin administration in the rat (2008) (0)
The synthesis of a novel dendritic system for gene delivery (2006) (0)
Solid phase synthesis of C-terminal glycopeptides via a modified Staudinger reaction (1999) (0)
Liposaccharide delivery system: application to conotoxin MII and endomorphin I (2004) (0)
Development of Multilayer Nanoparticles for the Delivery of Peptide-Based Subunit Vaccine against Group A Streptococcus (2022) (0)
Liposaccharide based peptide delivery system for tumour selective somatostatin analogues (2000) (0)
Evaluation of positively charged glucolipopeptides as oral absorption enhancers for the improvement of anionic drug delivery (2011) (0)
Lipid-core-peptides for vaccination: Structure-activity relationship (2002) (0)
Editorial: Drug Delivery Australia. (2015) (0)
Synthesis of C-linked sugar-lipoamino acid conjugates (2000) (0)
The Characterisation of Novel Dendritic Carriers with DNA by Isothermal Titration Calorimetry (2007) (0)
Uptake of a multi-component non-viral gene delivery system and gene expression in mammalian cells (2006) (0)
Lipid methyl transferase inhibitory activity of novel α-amino alkylic acid derivatives (1992) (0)
New benzimidazole derivatives, methods for production thereof and containing them medium (1976) (0)
Novel lipoamino acid based vaccine adjuvant carrier system (2007) (0)
Karboxylsyraderivat, deras syraadditionssalter Science foerfarande Foer framstaellning daerav. (1984) (0)
INVESTIGATION ON THE CHEMISTRY OF BERBANS, III. REGIOSPECIFIC SYNTHESIS OF DEPYRROLOYOHIMBINONE BY DIECKMANN CONDENSATION OF UNSATURATED ESTERS (1976) (0)
Synthetic Bicyclic Analogues of Quassinoids. (1998) (0)
Liposaccharides for drug and vaccine delivery (2004) (0)
Method for the preparation of substituted chloroacetanilides (1983) (0)
Design, synthesis and characterisation of mannosylated ovalbumin lipid core peptide self-adjuvanting vaccine delivery system (2013) (0)
[Antidiuretic effect of quinine derivatives]. (1952) (0)
Luteinizing Hormone Releasing Hormone/Galactose Core/Lipopeptide (2015) (0)
Impurities in gammaglobulin and albumin preparations: influence of the source material. (1974) (0)
Investigations On Chemistry of Berbans .5. Synthesis of 18-Acyloxy-10,11-Dimethoxy-(Depyrrolo)Alloyohimbinones (1977) (0)
[Investigation on the chemistry of berbans. I. Synthesis of dimethoxy-despyrrolo-yohimbine and dimethoxy-despyrrolo- -yohimbine]. (1972) (0)
INVESTIGATION ON THE CHEMISTRY OF BERBANS. VIII. SYNTHESIS OF “INSIDE” DEPYRROLOYOHIMBINE ANALOGS (1980) (0)
Problems in Sárospatak. (1985) (0)
[Evaluation of haptoglobin studies in neoplasms]. (1972) (0)
Flockbook recording in 1963-64. (1965) (0)
Charged liposaccarides for drug delivery (2002) (0)
New 1, 2, 3, 4, 6, 7-hexahydro-11 balphah-benzo (a) quinolizine derivatives and methods for making the same (1978) (0)
Liposomes as a delivery platform of vaccines against group a Streptoccocus (2015) (0)
Penicillin and Cephalosporin Conjugates with Lipidic Amino Acids and Oligomers (1992) (0)
Determination of the transport across CACO-2 cell monolayers of compounds varying in lipophilicity using LC-MS (2000) (0)
Synthesis of Benzo[A]Quinolizidine Derivatives Showing Anti-Inflammatory Activity Without Ulcerogen Side-Effect (1979) (0)
Lipidic amino acid based synthetic drug delivery system (1995) (0)
Method for preparation of phenylamines alkylated on the nucleus (1973) (0)
Semisynthetic Derivatives of Quassin. (1998) (0)
Structure—Serologic Relationships of the Immunodominant Site of Foot-and-Mouth Disease Virus (1994) (0)
Structure-retention relationships of diastereomeric mixtures of lipidic amino acid conjugates on reversed-phase stationary phases (1994) (0)
Applications of lipoamino acids and liposaccharides for peptide delivery and enhancing immunogenicity (2001) (0)
Analogous method for the manufacture of thiocarbamidderivater. (1968) (0)
Optimization of nuclear-localization in a Multicomponent Non-viral Gene Delivery System (2015) (0)
Enhanced Transdermal Peptide Delivery and Stability by Lipid Conjugation: Epidermal Permeation, Stereoselectivity and Mechanistic Insights (2014) (0)
Synthesis, structure elucidation and in vitro toxicity assessment of chlorambucil conjugates with lipidic acids, lipidic amino acids and their oligomers (1993) (0)
Novel Dde-protected glycoamino acids and glycoazido acids in saccharopeptide synthesis (2002) (0)
Peptide substrates for AMP-activated protein kinase. (1995) (0)
Liposaccharides in drug delivery (2002) (0)
Synthetic and conformational studies of the alpha subunit cytoplasmic domain of the immunoglobulin E receptor. (1992) (0)
Preparation and characterization of an IgG‐dehydroepiandrosterone conjugate (1998) (0)
Method for the production of clinically applicable human immunoglobulin preparation with high IgA content. (1972) (0)
Lipidic peptide conjugates of GABA with improved bioavailability (1991) (0)
Synthesis and biological assessment of baclofen conjugates with lipidic amino acids (1993) (0)
Polyelectrolyte coated liposome delivery systems against Group A Streptococcus (GAS) infection (2017) (0)
Double Conjugation Using Mercapto-Acryloyl and Alkyne-Azide Reactions for the Synthesis of Branched Multiantigenic Vaccine Candidates. (2021) (0)
[Evaluation of serum ceruloplasmin and haptoglobin levels in patients with non-Hodgkin lymphoma]. (1985) (0)
The eighth Australian peptide conference: Peptides – tools, targets and therapeutics (2011) (0)
Modeling Biologically Relevant Peptides Using Circular Dichroism with Synchrotron Radiation and High-Temperature Molecular Dynamics (1994) (0)
Novel liposaccharide based system for delivering LHRH orally. (2001) (0)
The lipid core peptide system in vaccine delivery (2006) (0)
Confinement of Triple-Enzyme-Involved Antioxidant Cascade in Two-Dimensional Nanostructure (2023) (0)
Parasite burden and parasitemia following vaccination and infection. (2012) (0)
Investigation of transfection & cell viability using high concentrations of lipidic dendrimeric lysine. (1999) (0)
Lipidic Peptides. Part 9. Synthesis and Structural Elucidation of Lipophilic Azidothymidine Conjugates. (1992) (0)
[Results of experiments with mesobiliviolin reaction]. (1955) (0)
Investigations on the Chemistry of Berbanes. Part 13. Selective Reduction of Normal-, Allo-, Pseudo-, and Epiallo-Depyrrolo-yohimbone Analogues. (1988) (0)
The Fourth International Peptide Symposium: discovery to drugs: the peptide pipeline. (2008) (0)
Vaccine design against streptococcal infection (2003) (0)
Modern methods of decision making. (1970) (0)
Synthetic BicycIic Analogues of Quassinoids (0)
Mitochondrial network in nervous system morphological and micro analytical evidences (1981) (0)
Lipidic Peptides. Part 7. Synthesis and Structure Elucidation of . gamma.‐Aminobutyric Acid Conjugates with Lipidic Acids, Lipidic Amino Acids and Lipidic Peptides. (1991) (0)
Berbanderivater or salts thereof, their preparation and use as medicaments (1986) (0)
Investigation of protein kinase substrate recognition (1994) (0)
A védőoltások gyógyszerkémiájának egyik legújabb fejezete. Zsír-aminosav komplexen alapuló vakcinák (Recent developments in prophylactic drug chemistry. Vaccines based on fatty-amino acid complexes) (2007) (0)
Lipidic amino acid and oligomer conjugates with saccharides and other highly hydrophilic compounds (1993) (0)
[Etiological role of various enteroviruses in different infectious diseases of children]. (1973) (0)
Synthetic vaccines: Enhanced immunogenicity of Streptococcus peptide epitopes. (2001) (0)
Studies on connections between quality of plasma and impurities of gamma globulin and albumin preparations. (1973) (0)
One-pot Multiple Enzyme Reaction for the Glycosylation of Leu-Enkephalins ; CNS Drug Delivery (2013) (0)
Lipids and sugars: Application for peptide delivery and for enhancing synthetic peptide immunogenicity (2001) (0)
Synthesis and characterisation of linear amphipathic lysine-lipid conjugates (2000) (0)
2-phenylhydrazinothiazolin- or 2-phenylhydrazinothiazininderivate as well as their use and methods of manufacture thereof (1974) (0)
[Serum ceruloplasmin in malignant diseases of the hematopoietic system]. (1972) (0)
Lipidic peptide elastase inhibitors with improved membrane association and high activity (1991) (0)
Synthesis of lipidic peptide conjugates of nucleoside antiviral and cytostatic agents (1992) (0)
Meet Our Editor (2015) (0)
Liposaccharides in peptide drug delivery (2004) (0)
Vaccine delivery utilizing liposaccharides (2007) (0)
Synthesis of lipidic phospho-ester conjugates of AZT (1993) (0)
Corrigendum: An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity. (2017) (0)
Investigations On Chemistry of Berbans .6. New Synthesis of 10-Methoxy(Depyrrolo)-Reserpine and its Stereoisomers (1977) (0)
The synthesis and immunological activity of a lipid-core peptide (LCP) based Human Papillomavirus (HPV) type-16 vaccine (2005) (0)
Gel filtration analysis of multiple myeloma sera. (1973) (0)
Short Communication Cellular transport pathways of polymer coated gold nanoparticles (2012) (0)
THANKS TO OUR SPONSORS AND SUPPORTERS (0)
Investigation on the chemistry of berbans—VIII : Synthesis of “inside” depyrrolo-yohimbine analogues (1979) (0)
INVESTIGATION ON THE CHEMISTRY OF BERBANS. VII. SYNTHESIS OF 10,11‐DIMETHOXY(DEPYRROLO)RAUNESCINE STEREOISOMERS (1978) (0)
Multi-epitopic lipid core peptide vaccine with broad protective immune responses against Group A streptococcus (2006) (0)
carbamate derivatives process for preparing urea and (1976) (0)
A novel lipoamino acid based system for delivery of Leu-enkephalinamide derivatives through the blood-brain barrier (2002) (0)
Lipidic Peptides. Part 14. Conversion of Racemic Lipidic Amino Acids into Sphingosine and Ceramide Analogues and 1,2-Diamines. (2010) (0)
2nd Annual Meeting of the Australian Chapter of the Controlled Release Society, Canberra 2009 (2009) (0)
Synthesis of C-linked lipoamino acid based glycolipids (2000) (0)
[Studies on sewage treatment]. (1953) (0)
[FACTS ON PREDIABETES]. (1963) (0)
Editorial (Thematic Issue: Drug Delivery Australia) (2015) (0)
Oral absorption of nanoparticles & dendrimers: facts & promise (1999) (0)
Synthesis and Biological Activity of Heteroalkyl Lipidic Amino Acids (1992) (0)
Lipid-core-peptides for vaccination: A structure-activity relationship study. (2001) (0)
Polymer-Peptide Conjugate Vaccine for Oral Immunization. (2021) (0)
Erratum for Rivera-Hernandez et al., “An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model” (2020) (0)
Nya 1,2,3,4,6,7-hexahydro-11b-H alpha benzo (a) kinolizinderivat Science foerfarande Foer deras framstaellning (1978) (0)
Peptide-based self-assembled nanovaccine system targeting Group A Streptococcus infection (2015) (0)
Vaccine delivery: synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate. (2009) (0)
Lipoamino acids and liposaccharides: Enhanced peptide delivery (2001) (0)
Novel liposaccharide based drug & peptide delivery systems (1999) (0)
A novel immunoadjuvant carrier system for synthetic peptides (2002) (0)
Drug Delivery Asia. (2019) (0)
Development of polymer-based nanoparticulate intranasal lipopeptide vaccine constructs against group A streptococcus (2019) (0)
Chemoselective peptide attachment to well-defined star polymer for peptide delivery (2006) (0)
Synthesis and characterisation of Trp modified Leu-Enkephalin analogues (2006) (0)
Lipoamino acid based glycoconjugates for peptide and drug delivery (2000) (0)
Dendritic delivery systems for peptide vaccines (2011) (0)
A study of heat-denaturation processes in 25 percent human albumin solutions. (1972) (0)
Synthetic vaccines built on carbohydrate cores (2001) (0)
A multiple antigen lipophilic adjuvant carrier system (MALAC) (2002) (0)
Lipoamino acid and glycolipid conjugated peptides enhanced intestinal absorption of an anti-tumour somatostatin analogue (2000) (0)
Lipid and carbohydrate based macromolecules in drug and vaccine delivery (2003) (0)
Synthesis of amphipathic lipoamino acid-based glycoconjugates PA061, 199 (1999) (0)
Synthesis of glycolipopeptides for self-assembling potential (2011) (0)
A protective immune response using asymmetric multi-epitope self-adjuvanting lipopeptide vaccine model (2015) (0)
Epitopes formes par association non covalente de conjugues (2000) (0)
Nanotechnology based delivery systems for vaccines (2018) (0)
Induction of high titred, non-neutralising antibodies by self-adjuvanting peptide epitopes derived from the respiratory syncytial virus fusion protein (2017) (0)
Liposaccharides in peptide, gene and vaccine delivery (2006) (0)
Synthesis of therapeutic vaccine against cervical cancer (2014) (0)
Peptide-Pegylated Lipid Conjugation Via Copper-Catalyzed Alkyne-Azide 1,3-Dipolar Cycloaddition. (2021) (0)
Liposaccharide delivery system: Application for peptide IT-100, LHRH and conotoxin MII (2003) (0)
Development of a Multivalent Heteroepitopic Group A Streptococcus Vaccine (2007) (0)
Synthesis of lipo- and liposaccharide a-conotoxin MII conjugates. (2001) (0)
Caco-2 cell permeability and stability assays of two d-glycopyranuronanamide conjugates of thyrotropic releasing hormone (2006) (0)
In vivo evaluation of intravitreally injected connexin 43 mimetic peptide in reducing retinal ganglion cell loss and vessel leak after retinal ischemia (2014) (0)
Dde as a Protecting Group for Carbohydrate Synthesis. (2006) (0)
Delivery of neuroactive peptide drugs to the brain via intranasal delivery (2006) (0)
Preparation of peptide functionalized nanoparticles by interfacial polymerisation of w/o microemulsions (2004) (0)
Incorporation of lipoamino acids - peptide conjugates within liposomes: Effect of alkyl chain length, number of alkyl chains and method of liposome preparation (2004) (0)
Drug delivery systems utilizing lipids and sugars (2003) (0)
Intestinal and intraperitoneal absorption and bioavailability of the antioxidants unconjugated bilirubin, biliverdin and bilirubin ditaurate in the rat (2008) (0)
Liposaccharide based vaccine carrier adjuvant systems (2006) (0)
[Evaluation of haptoglobin studies in tumorous diseases]. (1972) (0)
Liposacchride delivery system: Application to peptides conotoxin MII and endomorphin I (2003) (0)
Synthesis and Biological Activity of Self-adjuvanting Peptide-based Therapeutic Vaccine Against Cervical Cancer (2013) (0)
Perspectives in the vaccine development against Opisthorchis viverrini liver fluke (2022) (0)
GnRH Glycolipids with In Vitro Gonadotropin Hormone Releasing Properties and Direct Antiproliferative Activity on Prostate and Ovarian Cancer Cells (2014) (0)
Liposaccharides in Peptide Vaccine Delivery (2007) (0)
Vaccine delivery utilizing liposaccharides. (2009) (0)
Synthesis of amphipathic glycolipids for drug delivery (2000) (0)
A novel liposaccharide based system for peptide drug delivery (2000) (0)
Lipoamino acid based glycolipids for drug delivery (1999) (0)
Enhancement of Oral Drug Absorption - Effect of Lipid and Glycoside Conjugation on the Enzymatic Stability and Intestinal Permeability of IM862 (2007) (0)
Modify the bioactive to increase the availability and potency of a drug: Lipids and sugars in drug delivery and vaccine development (2002) (0)
Solid-phase synthesis of oligosaccharides utilising a novel Dde-based linker (2001) (0)
Back Cover: Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite (ChemMedChem 10/2015) (2015) (0)
The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines (2023) (0)
Drug development of endomorphin-1 (2006) (0)
The importance of epitope and lipid orientation in the design of synthetic self-adjuvanting group A streptococcal (GAS) vaccine (2007) (0)
Anti-proliferative effects of novel glyco-lipoaminoacid-modified arsenicals (III) on MCF-7 human breast cancer cells (2005) (0)
Design and synthesis of glucolipopeptides as potential cationic permeation enhancers for oral drug delivery (2011) (0)
A novel lipoamino acid based system for peptide delivery: Application for administering tumor selective somatostatin analogues (2002) (0)
Synthesis of Multicomponent Peptide-Based Vaccine Candidates against Group A Streptococcus (2017) (0)
Synthetic vaccines containing multiple copies of group A streptococcus peptide epitopes. (2001) (0)
REACTIONS OF CARBOHYDRATE TOSYLATES AND MESYLATES WITH NUCLEOPHILES: CONTROL OF INVERSIONS OF STEREOCHEMISTRY (2002) (0)
Multiepitope Subunit Peptide-Based Nanovaccine against Porcine Circovirus Type 2 (PCV2) Elicited High Antibody Titers in Vaccinated Mice (2023) (0)
Synthesis of lipoamino acid and liposaccharide based peptides for enhancement of oral bioavailability (2000) (0)
Enhanced immunogenicity of group A streptococcal peptide epitopes by lipoamino acid based adjuvant carrier system. (2001) (0)
A new approach to absorption enhancement based on the molecular structure of occludin (2000) (0)
Novel liposaccharide conjugates for drug/peptide delivery & enhancing synthetic peptide immunogenicity (1999) (0)
Synthesis of glycopeptide modified IgE epitopes (2002) (0)
Synthesis of Glycolipid-based Drug Delivery Systems for Oral Administration (2016) (0)
Lipoamino acid and liposaccharide conjugated peptides: Enhancement of bioavailability. (2001) (0)
Caco-2 cell permeability of peptide IT-100 and its conjugates; and investigation of transport mechanisms of sacchride conjugates (2001) (0)
INVESTIGATION ON THE CHEMISTRY OF BERBANS, IV. SYNTHESIS OF HALOGEN CONTAINING DEPYRROLOYOHIMBONE DERIVATIVES WITH PG-LIKE AND PG-ANTAGONISTIC EFFECT (1976) (0)
Vaccine delivery: Synthesis and investigation of a highly pure, multi-epitopic lipopeptide vaccine candidate (2007) (0)
The synthesis and biological activity of an orally available liposaccharide analogue of LHRH. (2001) (0)
Modern vaccine delivery systems (2015) (0)
C-linked sugar - lipoamino acid conjugates (2001) (0)
Nanoparticles-based peptide subunit vaccines against group A Streptococcus (2012) (0)
Lipid-core-peptides for vaccination. (2001) (0)
Development of vaccines for the prevention and/or treatment of human papillomavirus type-16 associated cervical cancer (2006) (0)
Development of totally synthetic self-adjuvanting vaccines against Group A streptococcus (2006) (0)
Enhancement of drug oral absorption - effect of lipidic conjugation on the stability and permeability of a dipeptide amide derivative in Caco-2 models (2006) (0)
Strategies for intranasal delivery of vaccines (2012) (0)
MICRO- AND NANOTECHNOLOGY IN VACCINE DEVELOPMENT INTRODUCTION (2017) (0)
Polyphenylalanine as a self-adjuvanting delivery system for peptide-based vaccines: the role of peptide conformation (2022) (0)
Transdermal Delivery of a Tetrapeptide: Evaluation of Passive Diffusion (2003) (0)
Preliminary pharmacokinetics of bilirubin administration in the rat (2007) (0)
Amide & ester type conjugates of methotrexate with lipoamino acids: preparation & antitumour activity (1999) (0)
Modified influenza virosomes for gene delivery (2006) (0)
Investigation of liposomal self-adjuvanting peptide epitopes derived from conserved blood-stage Plasmodium antigens (2022) (0)
Lipoamino Acid - Nucleobase Conjugates for Gene Delivery (2011) (0)
Development and delivery of a peptide-based vaccine against group A Streptococcus (2017) (0)
Dendritic vaccine delivery systems (2015) (0)
Introduction: A breakthrough in modern drug research (2003) (0)
Erratum to “Oral absorption studies of lipid-polylysine conjugates of thyrotropin releasing hormone (TRH1) and luteinizing hormone releasing hormone (LHRH1)” [Int. J. Pharm. 138 (1996) 167]1 (1996) (0)
Self-adjuvanting Peptide-based Subunit Nanovaccines (2011) (0)
Lipopeptide Nanoparticulate Vaccine Candidates for the Induction of Protective Immune Responses (2021) (0)
Synthesis of 2-amino-2-deoxy-glycoamino acids & glycolipids (1999) (0)
Glycolipid-modified peptides: Enhancement of absorption of an anti-tumour somatostatin analogue (2000) (0)
Targeting antigenic site on RSV F protein associated with virus neutralization for vaccine design (2015) (0)
Strategies in Oral Immunization (2009) (0)
Further characterization of an astrocyte secreted factor that increases transendothelial electrical resistance in an in vitro model of the blood-brain barrier (2001) (0)
Synthesis of cationic lipidic peptide dendrimer vectors for in vitro oligonucleotide delivery. (2001) (0)
Peptide-Based Multicomponent Oligonucleotide Delivery Systems: Optimisation of Poly-l-lysine Dendrons for Plasmid DNA Delivery (2016) (0)
Binding and immune modulation properties of mannosylated lipo-peptide vaccines (2015) (0)
Oligonucleotide gene therapy for choroidal neovascularisation enhanced by dendrimer mediated delivery (2003) (0)

This paper list is powered by the following services:

Other Resources About István Tóth

en.wikipedia.org

What Schools Are Affiliated With István Tóth ?

István Tóth is affiliated with the following schools:

István Tóth 's Academic­Influence.com Rankings